Evidence map›Paper›PMID 33440185›Full record

ReviewExperimental hematology2021

Erythroid enucleation: a gateway into a "bloody" world.

Vijay Menon, Saghi Ghaffari

Abstract readReview
In one paragraph

Review in Experimental hematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Molecular and therapeutic frontiers in anemia therapy.The Journal of clinical investigation · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Erythroblast enucleation at a glance.Journal of cell science · 2024
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Vijay MenonDepartment of Cell, Developmental & Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY.
Saghi GhaffariDepartment of Cell, Developmental & Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY; Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: Saghi.Ghaffari@mssm.edu.

Funding

(PQ5) Mitochondria in Leukemic Stem Cell Disease ProgressionR01CA205975 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GHAFFARI, SAGHI · 2016 to 2025
$3.9M
Mitochondria in the Regulation of Terminal ErythropoiesisR01HL136255 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SAGHI GHAFFARI · 2017 to 2026
$3.8M
NCI NIH HHS R01 CA205975NHLBI NIH HHS R01 HL136255
6 · The paper itself

Abstract

Erythropoiesis is an intricate process starting in hematopoietic stem cells and leading to the daily production of 200 billion red blood cells (RBCs). Enucleation is a greatly complex and rate-limiting step during terminal maturation of mammalian RBC production involving expulsion of the nucleus from the orthochromatic erythroblasts, resulting in the formation of reticulocytes. The dynamic enucleation process involves many factors ranging from cytoskeletal proteins to transcription factors to microRNAs. Lack of optimum terminal erythroid maturation and enucleation has been an impediment to optimum RBC production ex vivo. Major efforts in the past two decades have exposed some of the mechanisms that govern the enucleation process. This review focuses in detail on mechanisms implicated in enucleation and discusses the future perspectives of this fascinating process.

Indexed as

Cell NucleusErythropoiesisAnimalsBirdsCalciumChromatinColony-Forming Units AssayComputational BiologyCytokinesCytoskeletal ProteinsDNA-Binding ProteinsErythroblastsErythrocytesIntercellular Signaling Peptides and ProteinsMammalsMiceCalciumChromatinCytokinesCytoskeletal ProteinsDNA-Binding ProteinsIntercellular Signaling Peptides and ProteinsMicroRNAsProto-Oncogene ProteinsReceptors, Thyroid HormoneRepressor Proteinsrho GTP-Binding ProteinsTranscription Factors

Identifiers

PMID33440185
PMCPMC8147720

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.